Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
Velaparthi, U., Wittman, M., Liu, P., Stoffan, K., Zimmermann, K., Sang, X., Carboni, J., Li, A., Attar, R., Gottardis, M., Greer, A., Chang, C.Y., Jacobsen, B.L., Sack, J.S., Sun, Y., Langley, D.R., Balasubramanian, B., Vyas, D.(2007) Bioorg Med Chem Lett 17: 2317-2321
- PubMed: 17317169 
- DOI: https://doi.org/10.1016/j.bmcl.2007.01.102
- Primary Citation of Related Structures:  
2OJ9 - PubMed Abstract: 
The discovery and synthesis of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor 1-receptor (IGF-1R) are presented. Installing amine containing side chains at the 4-position of pyridone ring significantly improved the enzyme potency. SAR and biological activity of these compounds is presented.
Organizational Affiliation: 
Department of Discovery Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA. upender.velaparthi@bms.com